Bio-Matrix Scientific Group Inc. (BMSN) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Bio-Matrix Scientific Group Inc.
Fiscal year is October-September. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 0 0 -
COGS excluding D&A 0 0 0 0 -
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles - - 0 0 0
Gross Income 0 0 0 0 -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.14M 1.55M 665,747 795,426 1.53M
Research & Development 129,150 416,828 51,286 17,715 9,509
Other SG&A 1.01M 1.13M 614,461 777,711 1.52M
Other Operating Expense 871,858 116,632 0 0 0
Unusual Expense (30,000) 0 (42.18M) 41,688 0
EBIT after Unusual Expense 30,000 0 42.18M (41,688) 0
Non Operating Income/Expense (487,992) 0 (363,991) (87,136) 24,777
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 117,080 91,278 62,829 429,477 501,863
Gross Interest Expense 117,080 91,278 62,829 429,477 501,863
Interest Capitalized 0 0 0 0 0
Pretax Income (2.58M) (1.76M) 41.09M (1.35M) (2M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 (493,280) (399,082) 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.58M) (1.76M) 40.6M (1.75M) (2M)
Minority Interest Expense (93,995) (213,121) (229,845) 0 (8,833)
Net Income (2.49M) (1.55M) 40.83M (1.75M) (2M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.49M) (1.55M) 40.83M (1.75M) (2M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.49M) (1.55M) 40.83M (1.75M) (2M)
EPS (Basic) (0.08) (0.03) 0.57 (0.01) ()
Basic Shares Outstanding 32.68M 59.07M 71.5M 148.75M 1.38B
EPS (Diluted) (0.08) (0.03) 0.57 (0.01) ()
Diluted Shares Outstanding 32.68M 59.07M 72.07M 148.75M 1.38B
EBITDA (2.01M) (1.67M) (665,747) (795,426) (1.53M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Bio-Matrix Scientific Group Inc.
Fiscal year is October-September. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 0 0 -
COGS excluding D&A 0 0 0 0 -
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles - - 0 0 0
Gross Income 0 0 0 0 -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.14M 1.55M 665,747 795,426 1.53M
Research & Development 129,150 416,828 51,286 17,715 9,509
Other SG&A 1.01M 1.13M 614,461 777,711 1.52M
Other Operating Expense 871,858 116,632 0 0 0
Unusual Expense (30,000) 0 (42.18M) 41,688 0
EBIT after Unusual Expense 30,000 0 42.18M (41,688) 0
Non Operating Income/Expense (487,992) 0 (363,991) (87,136) 24,777
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 117,080 91,278 62,829 429,477 501,863
Gross Interest Expense 117,080 91,278 62,829 429,477 501,863
Interest Capitalized 0 0 0 0 0
Pretax Income (2.58M) (1.76M) 41.09M (1.35M) (2M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 (493,280) (399,082) 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.58M) (1.76M) 40.6M (1.75M) (2M)
Minority Interest Expense (93,995) (213,121) (229,845) 0 (8,833)
Net Income (2.49M) (1.55M) 40.83M (1.75M) (2M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.49M) (1.55M) 40.83M (1.75M) (2M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.49M) (1.55M) 40.83M (1.75M) (2M)
EPS (Basic) (0.08) (0.03) 0.57 (0.01) ()
Basic Shares Outstanding 32.68M 59.07M 71.5M 148.75M 1.38B
EPS (Diluted) (0.08) (0.03) 0.57 (0.01) ()
Diluted Shares Outstanding 32.68M 59.07M 72.07M 148.75M 1.38B
EBITDA (2.01M) (1.67M) (665,747) (795,426) (1.53M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
